Min You

Min You

Auto-generated profile, based on publicly available information

Min You

Department of Pharmaceutical Sciences, College of Pharmacy, Northeast Ohio Medical University, Rootstown, OH, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Journal of Hepatology
Verified
Journal Article
Open access
MYMin You
Min You
GAGavin Arteel
Gavin Arteel
Hepatic lipid metabolism is a series of complex processes that control influx and efflux of not only hepatic lipid pools, but also organismal pools. Lipid homeostasis is usually tightly controlled by expression, substrate supply, oxidation and secretion that keep hepatic lipid pools relatively constant. However, perturbations of any of these processes can lead to lipid accumulation in the liver. Although it is thought that these responses are hepatic arms of the 'thrifty genome', they are maladaptive in the context of chronic fatty liver diseases. Ethanol is likely unique among toxins, in that it perturbs almost all aspects of hepatic lipid metabolism. This complex response is due in part to the large metabolic demand placed on the organ by alcohol metabolism, but also appears to involve more nuanced changes in expression and substrate supply. The net effect is that steatosis is a rapid response to alcohol abuse. Although transient steatosis is largely an inert pathology, the chronicity of alcohol-related liver disease seems to require steatosis. Better and more specific understanding of the mechanisms by which alcohol causes steatosis may therefore translate into targeted therapies to treat alcohol-related liver disease and/or prevent its progression.

1 January 2020 in The American Journal of Pathology
Verified
Journal Article
Closed access
ZZZhou Zhou
Zhou Zhou
TYTing Jie Ye
Ting Jie Ye
EDElizabeth DeCaro
Elizabeth DeCaro
BBBrian Buehler
Brian Buehler
ZSZachary Stahl
Zachary Stahl
MYMin You
Min You

1 April 2015
Verified
Journal Article
Open access
PDF file
MYMin You
Min You
AJAlvin Jogasuria
Alvin Jogasuria
CTCharles Taylor
Charles Taylor
JWJiashin Wu
Jiashin Wu
Sirtuin 1 signaling and alcoholic fatty liver disease

12 March 2019 in Hepatology Communications
Verified
Journal Article
Open access
PDF file
ZZZhou Zhou
Zhou Zhou
TYTing Jie Ye
Ting Jie Ye
GBGregory Bonavita
Gregory Bonavita
MDMichael Daniels
Michael Daniels
NKNoah Kainrad
Noah Kainrad
MYMin You
Min You
Lipin‐1 is a Mg2+‐dependent phosphatidic acid phosphohydrolase involved in the generation of diacylglycerol during synthesis of phospholipids and triglycerides. Ethanol‐mediated inhibitory effects on adipose‐specific lipin‐1 expression were associated with experimental steatohepatitis in rodents. In the present study, using an adipose‐specific lipin‐1 overexpression transgenic (Lpin1‐Tg) mouse model, we tested a hypothesis that adipose‐specific lipin‐1 overexpression in mice might dampen ethanol‐induced liver damage. Experimental alcoholic steatohepatitis was induced by pair‐feeding ethanol to Lpin1‐Tg and wild‐type (WT) mice using the chronic‐plus‐binge ethanol feeding protocol. Unexpectedly, following the chronic‐plus‐binge ethanol challenge, Lpin1‐Tg mice exhibited much more pronounced steatosis, exacerbated inflammation, augmented elevation of serum liver enzymes, hepatobiliary damage, and fibrogenic responses compared with the WT mice. Mechanistically, overexpression of adipose lipin‐1 in mice facilitated the onset of hepatic ferroptosis, which is an iron‐dependent form of cell death, and subsequently induced ferroptotic liver damage in mice under ethanol exposure. Concurrently, adipose lipin‐1 overexpression induced defective adiponectin signaling pathways in ethanol‐fed mice. Conclusion: We identified ferroptosis as a mechanism in mediating the detrimental effects of adipose‐specific lipin‐1 overexpression in mice under chronic‐plus‐binge ethanol exposure. Our present study sheds light on potential therapeutic approaches for the prevention and treatment of human alcoholic steatohepatitis.

1 May 2015 in The American Journal of Pathology
Verified
Journal Article
Open access
HYHuquan Yin
Huquan Yin
XLXiaomei Liang
Xiaomei Liang
AJAlvin Jogasuria
Alvin Jogasuria
NDNicholas O. Davidson
Nicholas O. Davidson
MYMin You
Min You
Ethanol-mediated injury, combined with gut-derived lipopolysaccharide (LPS), provokes generation of proinflammatory cytokines in Kupffer cells, causing hepatic inflammation. Among the mediators of these effects, miR-217 aggravates ethanol-induced steatosis in hepatocytes. However, the role of miR-217 in ethanol-induced liver inflammation process is unknown. Here, we examined the role of miR-217 in the responses to ethanol, LPS, or a combination of ethanol and LPS in RAW 264.7 macrophages and in primary Kupffer cells. In macrophages, ethanol substantially exacerbated LPS-mediated induction of miR-217 and production of proinflammatory cytokines compared with LPS or ethanol alone. Consistently, ethanol administration to mice led to increases in miR-217 abundance and increased production of inflammatory cytokines in isolated primary Kupffer cells exposed to the combination of ethanol and LPS. miR-217 promoted combined ethanol and LPS-mediated inhibition of sirtuin 1 expression and activity in macrophages. Moreover, miR-217-mediated sirtuin 1 inhibition was accompanied by increased activities of two vital inflammatory regulators, NF-κB and the nuclear factor of activated T cells c4. Finally, adenovirus-mediated overexpression of miR-217 led to steatosis and inflammation in mice. These findings suggest that miR-217 is a pivotal regulator involved in ethanol-induced hepatic inflammation. Strategies to inhibit hepatic miR-217 could be a viable approach in attenuating alcoholic hepatitis.

1 September 2016 in The American Journal of Pathology
Verified
Journal Article
Closed access
YCYan Cai
Yan Cai
AJAlvin Jogasuria
Alvin Jogasuria
HYHuquan Yin
Huquan Yin
MXMing-Jiang Xu
Ming-Jiang Xu
XHXudong Hu
Xudong Hu
MYMin You
Min You